Process for preparing halogenated pyridine derivatives

US10766909B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10766909-B2
Application numberUS-201716312568-A
CountryUS
Kind codeB2
Filing dateJun 28, 2017
Priority dateJul 5, 2016
Publication dateSep 8, 2020
Grant dateSep 8, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a process for preparing halogenated pyridine derivatives of the formula (II) proceeding from compounds of the formula (I) via intermediates of the formula (IIIa) or (IIIb) where the radicals Q and W are each independently halogen, R 2 is halogen or —O-pivaloyl, and Y is halogen, CO 2 R 1 or NO 2 , where R 1 is (C 1 -C 6 )-alkyl or (C 1 -C 6 )-haloalkyl.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparing a compound of formula (II) wherein Q and W are each independently halogen, and Y is halogen, CO 2 R 1 or NO 2 , where R 1 is (C 1 -C 6 )-alkyl or (C 1 -C 6 )-haloalkyl, wherein, in a first process step a), a compound of formula (I) wherein W and Y each have the definitions given above, is reacted with an organozinc base of structure (NR 3 R 4 )—Zn—R 2 or (NR 3 R 4 ) 2 —Zn wherein R 2 is halogen or O-pivaloyl and R 3 and R 4 together form a —(CH 2 ) 4 —, —(CH 2 ) 5 — or —(CH 2 ) 2 O(CH 2 ) 2 — group, where each of these groups may optionally be substituted by 1, 2, 3 or 4 R 5 radicals and R 5 is selected from the group consisting of methyl, ethyl, n-propyl and i-propyl, to give a compound of formula (IIIa) or formula (IIIb) wherein W, Y and R 2 each have the definitions given above, wherein the step a) is conducted at a temperature between 30° C. and 80° C., and this compound of formula (IIIa) or (IIIb) is reacted in a second process step b) with a compound of the structure Q-X wherein X is halogen and Q has the abovementioned definition to give the compound of formula (II). 2. The process according to claim 1 , wherein Q and X have the same definition and are each iodine or bromine, W is fluorine or chlorine, R 2 is halogen, and Y is chlorine, bromine, CO 2 R 1 or NO 2 , where R 1 is (C 1 -C 4 )-alkyl. 3. The process according to claim 1 , wherein R 3 and R 4 together form a —(CH 2 ) 5 — group, where each of these groups may optionally be substituted by 1, 2, 3 or 4 R 5 radicals, and R 5 is selected from the group consisting of methyl and ethyl. 4. The process according to claim 1 , wherein Q and X have the same definition and are each iodine, W is fluorine, R 2 is chlorine, and Y is chlorine, bromine, CO 2 R 1 or NO 2 , where R 1 is methyl. 5. The process according to claim 1 , wherein R 3 and R 4 together form a —(CH 2 ) 5 — group substituted by 4 methyl groups. 6. The process according to claim 1 , wherein the organozinc base is a compound of formula (V) (TMP) x ZnCl 2-x ,  (V) wherein x is the number 1 or 2. 7. The process according to claim 1 , wherein the organozinc base is present in conjunction with an alkali metal halide or alkaline earth metal halide. 8. The process according to claim 1 , wherein the organozinc base is used in a total amount of 0.5 to 5 equivalents, based on the compound of formula (I). 9. The process according to claim 1 , wherein the compound Q-X is an elemental halogen, optionally F 2 , Cl 2 , Br 2 or I 2 . 10. The process according to claim 1 , wherein the compound Q-X is used in a total amount of 0.5 to 10.0 equivalents, based on the compound of formula (I). 11. The process according to claim 1 , that is conducted in the presence of a solvent selected from the group consisting of tetrahydrofuran (THF), 1,4-dioxane, diethyl ether, diglyme, methyl tert-butyl ether (MTBE), tert-amyl methyl ether (TAME), 2-methyl-THF, toluene, xylenes, mesitylene, ethylene carbonate, propylene carbonate, N,N-dimethylacetamide, N,N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), N-ethyl-2-pyrrolidone (NEP), N-butyl-2-pyrrolidone (NBP); N,N′-dimethylpropyleneurea (DMPU), halohydrocarbon, aromatic hydrocarbon, chlorohydrocarbon, tetrachloroethylene, tetrachloroethane, dichloropropane, methylene chloride, dichlorobutane, chloroform, carbon tetrachloride, trichloroethane, trichloroethylene, pentachloroethane, difluorobenzene, 1,2-dichloroethane, chlorobenzene, bromobenzene, dichlorobenzene, 1,2-dichlorobenzene, chlorotoluene, trichlorobenzene; 4-methoxybenzene, fluorinated aliphatic, fluorinated aromatic, trichlorotrifluoroethane, benzotrifluoride and 4-chlorobenzotrifluoride, or a mixture of at least two of these solvents with one another. 12. The process according to claim 11 , wherein the solvent is THF or N,N-dimethylformamide (DMF). 13. The process according to claim 1 , wherein step b) is conducted at a temperature between 0° C. and 80° C. 14. A compound of formula (IIIa) wherein W is fluorine, Y is halogen, C(O) 2 R 1 or N(O) 2 , where R 1 is (C 1 -C 6 )-alkyl or (C 1 -C 6 )-haloalkyl, and R 2 is halogen or O-pivaloyl. 15. A compound of formula (IIIb) wherein W is fluorine, and Y is halogen, CO 2 R 1 or NO 2 , where R 1 is (C 1 -C 6 )-alkyl or (C 1 -C 6 )-haloalkyl. 16. A compound of formula (II) wherein Q is iodine, W is fluorine, and Y is Br, C(O) 2 R 1 or N(O) 2 , where R 1 is (C 1 -C 6 )-alkyl or (C 1 -C 6 )-haloalkyl. 17. The process according to claim 2 , wherein R 2 is chlorine, bromine or iodine. 18. The process according to claim 7 , wherein the organozinc base is present in conjunction with lithium chloride or magnesium chloride. 19. The process according to claim 4 , wherein Y is bromine.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10766909B2 cover?
The present invention relates to a process for preparing halogenated pyridine derivatives of the formula (II) proceeding from compounds of the formula (I) via intermediates of the formula (IIIa) or (IIIb) where the radicals Q and W are each independently halogen, R 2 is halogen or —O-pivaloyl, and Y is halogen, CO 2 R 1 or NO 2 , where R 1 is (C 1 -C 6 )-alkyl…
Who is the assignee on this patent?
Bayer Cropscience Ag
What technology area does this patent fall under?
Primary CPC classification C07F3/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).